Your session is about to expire
← Back to Search
Bladder Biopsy for Bladder Cancer
N/A
Waitlist Available
Led By Guillherme Godoy, MD
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
Study Summary
This trial looks at whether taking a biopsy of a bladder tumor before treatment results in a better match between the tumor's stage and grade as determined by endoscopic impression and final pathology.
Eligible Conditions
- Bladder Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Improvement of the kappa agreement score between preoperative and postoperative assessment of stage and grade in non-muscle-invasive bladder tumors.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Bladder tumor biopsyExperimental Treatment1 Intervention
All subjects will undergo a bladder tumor biopsy followed by transurethral resection.
Find a Location
Who is running the clinical trial?
Baylor College of MedicineLead Sponsor
1,002 Previous Clinical Trials
6,002,774 Total Patients Enrolled
Guillherme Godoy, MDPrincipal InvestigatorBaylor College of Medicine
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently taking blood thinners or long-term NSAIDs, and have not stopped them before the cystoscopy.You are 21 years old or older, no matter if you are a man or a woman.You have been diagnosed with bladder cancer.You have bladder tumors that are not invasive and have not spread to the muscles, and there has been at least a 12-month gap since your last occurrence.You have bladder tumors that look flat and wide, possibly at an advanced stage.You have been diagnosed with a specific type of bladder cancer that affects the prostatic urethra or upper urinary tract.You have had bladder tumors that have grown into the muscles or spread beyond the bladder.
Research Study Groups:
This trial has the following groups:- Group 1: Bladder tumor biopsy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are currently involved in this clinical research?
"Yes, the information hosted on clinicaltrials.gov confirms that this trial has begun its search for participants since April 1st 2018 and was last updated January 14th 2022. This medical research seeks to enroll 30 individuals from one centre."
Answered by AI
Are there any open spots still available for participants in this experiment?
"According to clinicaltrials.gov, the process of recruitment for this medical study is still ongoing. This trial was publicly announced on April 1st 2018 and has been actively updated since January 14th 2022."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger